Company / Interest Expense
Aurinia Pharmaceuticals Inc. Interest Expense History
FY2023-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$2.8M
FY2023
5-year range
$2.8M / $2.8M
FY2023-FY2023
Trend
-
vs FY2022
Sector context
#36 of 44
Health Care
What the data says
Aurinia Pharmaceuticals Inc.'s interest expense of $3M is lower than 82% of companies in the Health Care sector (FY2023).
Based on SEC 10-K filings.
$3M in FY2023.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 44This company $2.8M Sector average $291.0M
▼
-99.0% below sector average
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $2.8M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026